Haemonetics (HAE) Tops Q3 EPS by 11c
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $102.84 -0.08%
EPS Growth %: 0.0%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: 0.0%
Financial Fact:
Total operating expenses: 79.45M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.84, $0.11 better than the analyst estimate of $0.73. Revenue for the quarter came in at $260 million versus the consensus estimate of $266.94 million.
GUIDANCE:
Haemonetics sees FY2022 EPS of $2.45-$2.55, versus the consensus of $2.53.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Casey's General Stores (CASY) Tops Q1 EPS by 69c
- Barnes & Noble Education (BNED) Tops Q1 EPS by 12c
- ServiceTitan, Inc. (TTAN) Misses Q2 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
